Literature DB >> 11342916

Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.

J L Gore1, S F Shariat, B J Miles, D Kadmon, N Jiang, T M Wheeler, K M Slawin.   

Abstract

PURPOSE: The standard sextant protocol for obtaining transrectal ultrasound guided biopsy of the prostate has been shown to underestimate the presence of prostate cancer. Studies have demonstrated an increased cancer detection rate with additional laterally directed biopsies. We compared the sensitivity of individual biopsy cores and evaluated combinations of these cores to identify an optimal biopsy strategy.
MATERIALS AND METHODS: A total of 396 consecutive patients underwent biopsy of the lateral peripheral zone in addition to standard sextant biopsy. The cancer detection rate for each biopsy core was calculated. The sensitivity of different combinations of biopsy cores was compared with those of standard sextant biopsies and with a 12 core biopsy protocol that combined the standard sextant biopsy with a complete set of laterally directed cores.
RESULTS: Cancer was detected in 160 of 396 (40.3%) patients. Of the possible combinations of biopsy cores a strategy that included laterally directed cores at the base, mid gland and apex of the prostate with mid lobar base and apical cores detected 98.5% of cancers. The detection rate of this 10 core biopsy regimen was significantly better than that of the standard sextant protocol (p < or =0.001), and was equivalent to that of the 12 core regional biopsy (p > or =0.302).
CONCLUSIONS: The standard sextant protocol failed to detect a large proportion of cancers located laterally in the peripheral zone. A 10 core biopsy regimen that combined laterally directed cores at the base, mid gland and apex of the prostate with mid lobar biopsy cores at the base and apex maximizes the sensitivity of transrectal ultrasound guided systematic biopsy.

Entities:  

Mesh:

Year:  2001        PMID: 11342916

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  44 in total

Review 1.  The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis.

Authors:  Peng-Fei Shen; Yu-Chun Zhu; Wu-Ran Wei; Yong-Zhong Li; Jie Yang; Yu-Tao Li; Ding-Ming Li; Jia Wang; Hao Zeng
Journal:  Asian J Androl       Date:  2011-11-21       Impact factor: 3.285

Review 2.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

3.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

4.  Optimizing prostate biopsy strategies for the diagnosis of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

5.  Prostate biopsy: current status and limitations.

Authors:  Joseph C Presti
Journal:  Rev Urol       Date:  2007

6.  Endoclipping treatment of life-threatening rectal bleeding after prostate biopsy.

Authors:  Panagiotis Katsinelos; Jannis Kountouras; Georgios Dimitriadis; Grigoris Chatzimavroudis; Christos Zavos; Ioannis Pilpilidis; George Paroutoglou; George Germanidis; Kostas Mimidis
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

7.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

Review 8.  Prostate Cancer Screening.

Authors:  William J Catalona
Journal:  Med Clin North Am       Date:  2018-03       Impact factor: 5.456

9.  Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Authors:  Hasan Yılmaz; Ufuk Yavuz; Murat Üstüner; Seyfettin Çiftçi; Hikmet Yaşar; Bahar Müezzinoğlu; Ali Kemal Uslubaş; Özdal Dillioğlugil
Journal:  Turk J Urol       Date:  2017-07-31

10.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.